Furthermore, reduced DYN1 can prevent Aβ and phosphorylation of tau-induced mitochondrial dysfunction and synaptic damage in AD (Kandimalla et al., 2016; Manczak et al., 2016). This evidence concerns the gene MAPT and Alzheimer disease.